Alok Vyas

753 total citations
13 papers, 632 citations indexed

About

Alok Vyas is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Alok Vyas has authored 13 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Alok Vyas's work include Curcumin's Biomedical Applications (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Natural product bioactivities and synthesis (3 papers). Alok Vyas is often cited by papers focused on Curcumin's Biomedical Applications (4 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Natural product bioactivities and synthesis (3 papers). Alok Vyas collaborates with scholars based in India, United States and Greece. Alok Vyas's co-authors include Subhash Padhyé, Aamir Ahmad, Fazlul H. Sarkar, Prasad Dandawate, Abeda Jamadar, K. Venkateswara Swamy, Sanjeev Banerjee, Jyoti Deshpande, Rainer Schobert and Bernhard Biersack and has published in prestigious journals such as Pharmaceutical Research, Oncotarget and Current Pharmaceutical Design.

In The Last Decade

Alok Vyas

13 papers receiving 621 citations

Peers

Countries citing papers authored by Alok Vyas

Since Specialization

Citations

This map shows the geographic impact of Alok Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok Vyas more than expected).

Fields of papers citing papers by Alok Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alok Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok Vyas. The network helps show where Alok Vyas may publish in the future.

Co-authorship network of co-authors of Alok Vyas

This figure shows the co-authorship network connecting the top 25 collaborators of Alok Vyas. A scholar is included among the top collaborators of Alok Vyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alok Vyas. Alok Vyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A novel SOD mimic with a redox-modulating mn (II) complex, ML1 attenuates high glucose-induced abnormalities in intracellular Ca 2+ transients and prevents cardiac cell death through restoration of mitochondrial function 2016 ·Biochemistry and Biophysics Reports ·Vasundhara Kain, (unknown), (unknown), (unknown), Alok Vyas, Subhash Padhyé, Sandhya L. Sitasawad	7
2	Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis 2016 ·Oncotarget ·Fernando F. Blanco, Ranjan Preet, Andrea Aguado, Vikalp Vishwakarma, Laura E. Stevens, Alok Vyas, Subhash Padhyé, Liang Xu, Scott J. Weir, Shrikant Anant, Nicole Meisner‐Kober, Jonathan R. Brody, Dan A. Dixon	92
3	Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer 2014 ·Medicinal Chemistry Research ·Suniti Misra, Shibnath Ghatak, Alok Vyas, Paul E. O’Brien, Roger R. Markwald, Madhukar Khetmalas, Vincent Hascall, James B. McCarthy, Nikos K. Karamanos, Markku Tammi, Raija Tammi, (unknown), Subhash Padhyé	6
4	Novel Mn-SOD Mimetics Offer Superior Protection Against Oxidative Damages in Hek293 Kidney Cells 2014 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Alok Vyas, Vasundhara Kain, Zahra Afrasiabi, Sandhya L. Sitasawad, Madhukar Khetmalas, Vincent Nivière, Subhash Padhyé	2
5	Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities 2013 ·Bioorganic & Medicinal Chemistry Letters ·Shibnath Ghatak, Alok Vyas, Suniti Misra, Paul E. O’Brien, Ajit Zambre, Victor M. Fresco, Roger R. Markwald, (unknown), Zahra Afrasiabi, Amitava Choudhury, Madhukar Khetmalas, Subhash Padhyé	34
6	Targeting triple negative breast cancer cells by N3-substituted 9,10-Phenanthrenequinone thiosemicarbazones and their metal complexes 2013 ·Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy ·Zahra Afrasiabi, (unknown), (unknown), Amitava Choudhury, Charles L. Barnes, Aamir Ahmad, Fazlul H. Sarkar, Alok Vyas, Subhash Padhyé	19
7	Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties 2013 ·Current Pharmaceutical Design ·Alok Vyas, Prasad Dandawate, Subhash Padhyé, Aamir Ahmad, Fazlul H. Sarkar	37
8	Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties 2013 ·Current Pharmaceutical Design ·Alok Vyas, Prasad Dandawate, Subhash Padhyé, Aamir Ahmad, Fazlul H. Sarkar	83
9	Metal-based anticancer agents: targeting androgen-dependent and androgen-independent prostate and COX-positive pancreatic cancer cells by phenanthrenequinone semicarbazone and its metal complexes 2013 ·Transition Metal Chemistry ·Zahra Afrasiabi, (unknown), Di Xiao, Ekkehard Sinn, Amitava Choudhury, Aamir Ahmad, Alok Vyas, Fazlul H. Sarkar, Subhash Padhyé	3
10	Perspectives on new synthetic curcumin analogs and their potential anticancer properties. 2013 ·PubMed ·Alok Vyas, Prasad Dandawate, Subhash Padhyé, Aamir Ahmad, Fazlul H. Sarkar	149
11	Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer 2012 ·Pharmaceutical Research ·Prasad Dandawate, Alok Vyas, Aamir Ahmad, Sanjeev Banerjee, Jyoti Deshpande, K. Venkateswara Swamy, Abeda Jamadar, (unknown), Subhash Padhyé, Fazlul H. Sarkar	110
12	From Body Art to Anticancer Activities: Perspectives on Medicinal Properties of Henna 2012 ·Current Drug Targets ·(unknown), Prasad Dandawate, Alok Vyas, Subhash Padhyé, Bernhard Biersack, Rainer Schobert, Aamir Ahmad, Fazlul H. Sarkar	82
13	ATRA-hydrazonate derivatives and their copper complexes against hormone-dependent (MCF-7), hormone-independent (MDA-MB-231and BT-20) breast cancer and androgen-independent (PC3) prostate cancer cell lines 2012 ·Inorganic Chemistry Communications ·Alok Vyas, (unknown), Abeda Jamadar, Shreelekha Adsule, Subhash Padhyé, Aamir Ahmad, Fazlul H. Sarkar	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact